Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes-Reference-Cited by-同舟云学术

Effects of dapagliflozin on insulin-requirement, glucose excretion and ß-hydroxybutyrate levels are not related to baseline HbA1c in youth with type 1 diabetes

Published:2017-06-22 Issue:11 Volume:19 Page:1635-1639
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Biester Torben¹^ORCID,Aschemeier Baerbel¹,Fath Maryam¹,Frey Marcel²,Scheerer Markus F.³,Kordonouri Olga¹,Danne Thomas¹

Affiliation:

1. AUF DER BULT, Children's Hospital; Hannover Germany

2. Alcedis GmbH; Giessen Germany

3. AstraZeneca GmbH; Wedel Germany

Funder

AstraZeneca

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12975/fullpdf

Reference20 articles.

1. A contrast between children and adolescents with excellent and poor control: the T1D exchange clinic registry experience;Campbell;Pediatr Diabetes,2014

2. Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes;List;Diabetes Care,2009

3. Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial;Ferrannini;Diabetes Care,2010

4. Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data;Del Prato;Diabetes Obes Metab,2015

5. Dapagliflozin improves glycemic control and reduced body weight as add-on therapy to metformin plus sulfonylurea;Matthaei;Diabetes Care,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin-induced abnormal uterine bleeding in a patient with dilated cardiomyopathy and chronic heart failure: a case report;Journal of International Medical Research;2024-08

2. Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in children and young adults: a systematic review and meta-analysis;Annals of Pediatric Endocrinology & Metabolism;2024-04-30

3. Dapagliflozin and Empagliflozin in Paediatric Indications: A Systematic Review;Pediatric Drugs;2024-04-18

4. Clinical studies of dapagliflozin in pediatric patients: a rapid review;Annals of Pediatric Endocrinology & Metabolism;2022-12-31

5. Sodium-glucose co-transporter-2 inhibitors in Type 1 Diabetes: A Scoping Review;Hormone Research in Paediatrics;2022-10-24